U.S. pharma large copyright scrapped two experimental weight loss supplements last year—a the moment-each day tablet, lotiglipron, on account of elevated liver enzymes and a twice-every day capsule, danuglipron, due to potent Unwanted side effects—but CEO Albert Bourla has said the company is decided to “Enjoy and earn” within the being ove